Market
H.C. Wainwright slashes price target on Virax Biolabs Group Ltd [VRAX] – find out why.
Virax Biolabs Group Ltd [NASDAQ: VRAX] loss -3.54% or -0.04 points to close at $0.99 with a heavy trading volume of 181914 shares. The daily chart for VRAX points out that the company has recorded -41.56% loss over the past six months. If we look
